Keywords: bayer, offer, schering, ag, unchanged, despite, ultravist

Bayer offer for Schering AG unchanged, despite Ultravist news

Article | 07 August 2006

Print This

Following the announcement by Schering AG that it is voluntarily withdrawing its X-ray contrast media agent Ultravist injection 370mgl/ml ( ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in